Tag Archives: oncolytic

Controlling Your Destiny: Why Investment in Manufacturing Capabilities Makes Sense
May 28, 2020

By Philip Astley-Sparke, CEO of Replimune, as part of the From The Trenches feature of LifeSciVC. Manufacturing of medicines based on biology is complex. Viral vector manufacturing to produce gene therapy constructs, vaccines and oncolytic viruses is especially intricate. Most

Leave a comment